CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to VRXA

Phase 2

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Oct '26
VRXAPhase 2
✓Completed

VY7523 Phase 2 Est. Readout

VY7523
Oct 2026~
CT.gov
Competitive Landscape

0 competitors in Alzheimer's Disease (AD)

View Full Landscape
Drug Information

Target Indication

Alzheimer's Disease (AD)

Clinical Trial

NCT06874621

Last updated: 10/16/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.